BIOMAT Database Logo BIOMAT Database Logo

Active specific immunotherapy of melanoma: clinical results and correlates. 1989

M S Mitchell
USC Cancer Center, Los Angeles.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M S Mitchell
Specific active immunotherapy for melanoma.
September 1979, Annals of surgery,
M S Mitchell
[Active specific immunotherapy of malignant melanoma].
August 1997, Harefuah,
M S Mitchell
Active specific immunotherapy in malignant melanoma.
January 1989, Seminars in surgical oncology,
M S Mitchell
Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma.
August 1976, British journal of cancer,
M S Mitchell
Active specific and active non-specific immunotherapy in patients with malignant melanoma.
January 1977, Oncology,
M S Mitchell
Active specific immunotherapy with vaccinia melanoma oncolysate.
May 1992, The Mount Sinai journal of medicine, New York,
M S Mitchell
Overview of melanoma vaccines: active specific immunotherapy for melanoma patients.
June 1998, Seminars in surgical oncology,
M S Mitchell
Active antigen-specific immunotherapy of melanoma: from basic science to clinical investigation.
June 2005, World journal of surgery,
M S Mitchell
Specific active lung cancer immunotherapy. Immune correlates of clinical responses and an update of immunotherapy trials evaluations.
October 1988, Cancer,
M S Mitchell
Active specific adjuvant immunotherapy with vaccinia melanoma oncolysate.
January 1992, Annals of plastic surgery,
Copied contents to your clipboard!